mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics

H. Pópulo, P. Soares, A. Faustino, A. S. Rocha, P. Silva, F. Azevedo, J. M. Lopes
  • Pigment Cell & Melanoma Research, November 2010, Wiley
  • DOI: 10.1111/j.1755-148x.2010.00796.x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/j.1755-148x.2010.00796.x

The following have contributed to this page: Paula Soares and MD, PhD José Lopes